share_log

Those Who Invested in Stryker (NYSE:SYK) Five Years Ago Are up 60%

Those Who Invested in Stryker (NYSE:SYK) Five Years Ago Are up 60%

那些五年前投資於Stryker (紐交所:SYK) 的人現在獲利了60%。
Simply Wall St ·  08/14 08:30

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the market. Unfortunately for shareholders, while the Stryker Corporation (NYSE:SYK) share price is up 51% in the last five years, that's less than the market return. Zooming in, the stock is up a respectable 15% in the last year.

如果您購買並持有一支股票多年,希望能獲得利潤。此外,您通常希望看到股價上漲比市場快。不幸的是,對於股東而言,儘管Stryker Corporation (紐交所:SYK)的股價在過去五年中上漲了51%,但仍低於市場回報。縮小範圍後,股票在過去一年中上漲了15%。

So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns.

因此,讓我們評估過去5年的基本面,看看它們是否和股東的回報率相符。

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

爲了概述本傑明·格雷厄姆(Benjamin Graham)的話:短期內,市場是一臺投票機,但長期來看,它是一臺衡重機。思考一家公司的市場感知如何轉變的一種不完美但簡單的方法是將每股收益(EPS)變化與股價變動進行比較。

Stryker's earnings per share are down 1.0% per year, despite strong share price performance over five years.

儘管在過去五年中股價表現強勁,但Stryker的每股收益年降1.0%。

So it's hard to argue that the earnings per share are the best metric to judge the company, as it may not be optimized for profits at this point. Since the change in EPS doesn't seem to correlate with the change in share price, it's worth taking a look at other metrics.

因此,很難說每股收益是評判公司的最佳指標,因爲此時它可能沒有針對利潤進行優化。由於每股收益的變化似乎與股價的變化無關,因此值得查看其他指標。

The modest 1.0% dividend yield is unlikely to be propping up the share price. In contrast revenue growth of 9.0% per year is probably viewed as evidence that Stryker is growing, a real positive. It's quite possible that management are prioritizing revenue growth over EPS growth at the moment.

適度的1.0%紅利收益率不可能撐起股價。相比之下,年增長率達9.0%的營業收入可能被視爲Stryker正在增長的證據,並具有真正的積極意義。目前管理層很有可能將營收增長置於每股收益增長之上。

The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail).

下圖顯示了收益和營收隨時間變化的情況(如果你點擊圖像,可以看到更多細節):

big
NYSE:SYK Earnings and Revenue Growth August 14th 2024
紐交所:SYK的收益和營業收入增長日期爲2024年8月14日。

Stryker is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. Given we have quite a good number of analyst forecasts, it might be well worth checking out this free chart depicting consensus estimates.

Stryker是一支廣受關注的股票,有許多分析師關注,表明對未來增長有一定的可見度。鑑於我們有相當數量的分析師預測,查看這個免費的圖表以呈現共識預測可能非常值得。

What About Dividends?

那麼分紅怎麼樣呢?

As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Stryker the TSR over the last 5 years was 60%, which is better than the share price return mentioned above. This is largely a result of its dividend payments!

除了衡量股價回報,投資者還應考慮總股東回報(TSR)。 TSR包括任何分拆價值或折價募資價值,以及根據股息再投資假設計算的任何股息。可以說TSR給出了一個更全面的股票回報圖景。我們注意到,在過去的5年中,Stryker的TSR爲60%,優於上述股價回報。這在很大程度上是其股息支付的結果!

A Different Perspective

不同的觀點

Stryker shareholders are up 17% for the year (even including dividends). But that return falls short of the market. The silver lining is that the gain was actually better than the average annual return of 10% per year over five year. This could indicate that the company is winning over new investors, as it pursues its strategy. It's always interesting to track share price performance over the longer term. But to understand Stryker better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Stryker you should know about.

即使包括股息,Stryker的股東今年僅獲得了17%的回報,但該回報仍低於市場。積極的一面是,該增長實際上比過去5年的平均年回報率10%更好。這可能表明,隨着公司推進其策略,公司正在贏得新投資者的青睞。跟蹤較長期的股價表現始終很有趣。但爲了更好地了解Stryker,我們需要考慮許多其他因素。例如,考慮風險。每個公司都有風險,我們已經發現Stryker有2個值得注意的警告信號,您應該了解。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation).

如果您喜歡與管理層一起購買股票,那麼您可能會喜歡這個公司的免費列表。 (提示:其中許多公司不爲人注意且具有吸引力的估值。)

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論